knowledge -WSS

knowledge

author：focus 2025-10-01 01:49:18 - browse：144

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Health tech investors get more selective as pandemic boom fades

knowledge

WSS

With psoriasis trial ahead, Alumis raises $259 million

Health tech investors get more selective as pandemic boom fades

Change Healthcare cyberattack prompts Medicare loan program

Change Healthcare payments predicted restored March 15

Change Healthcare payments predicted restored March 15

How AI can help patients find reliable information about doctors

entertainment

knowledge

explore

After affirmative action ruling, medical educators look to 'holistic review'

The problem with charging patients to message their doctors

At least 13 dead in Texas as scorching temps continue

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Medicare details structure of new drug price negotiation program

STAT Summit: Meghan O’Rourke on making chronic illness visible

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth quietly bought dozens of outpatient centers

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth, Optum discontinue NaviHealth name

hotspot

Sen. Paul opposes bill to ban Chinese biotechs

Roche drug slashes death risk in early

The problem with charging patients to message their doctors

What it’s like to watch children die of measles

What it’s like to watch children die of measles

CZI to create biohub to build anti

leisure time

knowledge

focus

hotspot